secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2023-11-17T23:59:59+00:00
Accession:  0001193125-23-279821
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics receives Nasdaq deficiency notice for MVPHS below $5M
------------------------------------------------------------------------

- Received Nasdaq deficiency letter Nov 15, 2023 for failing MVPHS Rule 5450(b)(1)(C) for 35 consecutive days.
- Market value of publicly held shares below $5M minimum required for continued listing on Nasdaq Global Select Market.
- Compliance period through May 13, 2024; must meet $5M threshold for 10 consecutive business days to regain compliance.
- If non-compliant, company may consider transferring to Nasdaq Capital Market; delisting possible if not cured.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000119312523279821/0001193125-23-279821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000119312523279821/d405238d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-279821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer